Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 197-204 , March 2010

Clinical significance of the positive surgical margin based upon location, grade, and stage

  • Neil E. Fleshner, M.D., M.P.H., F.R.S.C.S.

      Affiliations

    • Division of Urology, University Health Network and Department of Surgery, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +416-946-2899; fax: +416-946-6590
    • ,
  • Andrew Evans, M.D., Ph.D.

      Affiliations

    • Department of Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Karen Chadwick, M.S.C.

      Affiliations

    • Division of Urology, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Nathan Lawrentschuk, M.B., B.S., F.R.A.C.S.

      Affiliations

    • Division of Urology, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Alexandre Zlotta, M.D.

      Affiliations

    • Mount Sinai Hospital and Department of Surgery, University of Toronto, Toronto, Ontario, Canada

References 

  1. American Cancer Society. Cancer Facts and Figures 2007. Atlanta (GA): American Cancer Society; 2007;
  2. Cooperberg MR, Broering JM, Litwin MS, et al. CaPSURE Investigators The contemporary management of prostate cancer in the United States: Lessons from the cancer of the prostate strategic urologic research endeavor (CaPSURE), a national disease registry. J Urol. 2004;171:1393–1401
  3. Bill-Axelson A, Holmberh L, Ruutu M, et al. Radical prostatectomy vs. watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977–1984
  4. Bott SR, Kirby RS. Avoidance and management of positive surgical margins before, during, and after radical prostatectomy. Prostate Cancer Prostatic Dis. 2002;5:252–263
  5. Ohori M, Wheeler TM, Kattan MW, et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol. 1995;154:1818–1824
  6. Srigley J, Amin MB, Humphreys PA, for the Members of the Cancer Committee College of American Pathologists. Prostate 2006. Northfield (IL): College of American Pathologists [cited Oct 2005].
  7. Ward JF, Zincke H, Bergstralh EJ, et al. The impact of surgical approach (nerve bundle preservation vs. wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J Urol. 2004;172(4 Pt 1):t-32
  8. Karakiewicz PI, Eastham JA, Graefen M, et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5,831 patients. Urology. 2005;66:1245–1250
  9. Eastham JA, Kattan MW, Riedel E, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol. 2003;170(6 Pt 1):t5
  10. Chun FK, Briganti A, Antebi E, et al. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients. BJU Int. 2006;98:1204–1209
  11. Blute ML, Bostwick DG, Bergstralh EJ, et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology. 1997;50:733–739
  12. Khan MA, Partin AW, Mangold LA, et al. Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer. Urology. 2003;62:866–871
  13. Bianco FJ, Riedel ER, Begg CB, et al. Variations among high volume surgeons in the rate of complications after radical prostatectomy: Further evidence that technique matters. J Urol. 2005;173:2099–2103
  14. Freedland SJ, Aronson W, Presti JC, et al. Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? (Results from the SEARCH database). J Urol. 2003;169:2142–2146
  15. Swindle P, Eastham JA, Ohori M, et al. Do margins matter? (The prognostic significance of positive surgical margins in radical prostatectomy specimens). J Urol. 2005;174:903–907
  16. Palisaar RJ, Noldus J, Graefen M, et al. Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure. Eur Urol. 2005;47:176–184
  17. Orvieto MA, Alsikafi NF, Shalhav AL, et al. Impact of surgical margin status on long-term cancer control after radical prostatectomy. BJU Int. 2006;98:1199–1203
  18. Berger AP, Volgger H, Rogatsch H, et al. Screening with low PSA cutoff values results in low rates of positive surgical margins in radical prostatectomy specimens. Prostate. 2002;53:24–25
  19. Kausik SJ, Blute ML, Sebo TJ, et al. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer. 2002;95:1215–1219
  20. Marcovich R, Wojno KJ, Wei JT, et al. Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer. Urology. 2000;55:904–908
  21. Sofer M, Hamilton-Nelson KL, Civantos F, et al. Positive surgical margins after radical retropubic prostatectomy: The influence of site and number on progression. J Urol. 2002;167:2453–2456
  22. Sofer M, Hamilton-Nelson KL, Schlesselman JJ, et al. Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. J Clin Oncol. 2002;20:1853–1858
  23. Fesseha T, Sakr W, Grignon D, et al. Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol. 1997;158:2176–2179
  24. Salomon L, Anastasiadis AG, Antiphon P, et al. Prognostic consequences of the location of positive surgical margins in organ-confined prostate cancer. Urol Int. 2003;70:291–296
  25. Lepor H, Kaci L. Role of intraoperative biopsies during radical retropubic prostatectomy. Urology. 2004;63:499–502
  26. Pettus JA, Weight CJ, Thompson CJ, et al. Biochemical failure in men following radical retropubic prostatectomy: Impact of surgical margin status and location. J Urol. 2004;172:129–132
  27. Cannon GM, Pound CR, Landsittel DP, et al. Perineural invasion in prostate cancer biopsies is not associated with higher rates of positive surgical margins. Prostate. 2005;63:336–340
  28. Rapp DE, Orvieto MA, Lucioni A, et al. Intraoperative prostate examination: Predictive value and effect on margin status. BJU Int. 2005;96:1005–1008
  29. Cohn JH, El-Galley R. Radical prostatectomy in a community practice. J Urol. 2002;167:224–228
  30. Emerson RE, Koch MO, Jones TD, et al. The influence of extent of surgical margin positivity on prostate specific antigen recurrence. J Clin Pathol. 2005;58:1028–1032
  31. Cheng L, Slezak J, Bergstralh EJ, et al. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy. J Clin Oncol. 2000;18:2862–2868
  32. Graefen M, Hammerer P, Michl U, et al. Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy. Urology. 1998;51:437–442
  33. Vis AN, Schroder FH, van der Kwast TH. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol. 2006;50:258–265
  34. Rabbani F, Bastar A, Fair WR. Site-specific predictors of positive margins at radical prostatectomy: An argument for risk based modification of technique. J Urol. 1998;160:1727–1733
  35. Hsu EI, Hong EK, Lepor H. Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy. Urology. 2003;61:601–606
  36. Lowe BA. Comparison of bladder neck preservation to bladder neck resection in maintaining post-prostatectomy urinary continence. Urology. 1996;48:889–893
  37. Lee DK, Allareddy V, O'donnell MA, et al. Does the interval between prostate biopsy and radical prostatectomy affect the immediate postoperative outcome?. BJU Int. 2006;97:48–50
  38. Aydin H, Tsuzuki T, Hernandez D, et al. Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression. Urology. 2004;64:551–555
  39. Deliveliotis C, Protogerou V, Alargof E, et al. Radical prostatectomy: Bladder neck preservation and puboprostatic ligament sparing—effects on continence and positive margins. Urology. 2002;60:855–858
  40. Alsikafi NF, Brendler CB. Surgical modifications of radical retropubic prostatectomy to decrease incidence of positive surgical margins. J Urol. 1998;159:1281–1285
  41. Salomon L, Anastasiadis AG, Johnson CW, et al. Seminal vesicle involvement after radical prostatectomy: Predicting risk factors for progression. Urology. 2003;62:304–309
  42. Richman M, McLaughlin S, Maygarden S, et al. Initial incision of lateral pelvic fascia and early ligation of vascular pedicles during radical prostatectomy: Potential to reduce positive margin rates. BJU Int. 2005;95:40–45
  43. Guillonneau B, Cathelineau X, Doublet JD, et al. Laparoscopic radical prostatectomy: Assessment after 550 procedures. Crit Rev Oncol Hematol. 2002;43:123–133
  44. Guilloneau B, el-Fettouh H, Baumert H, et al. Laparoscopic radical prostatectomy: Oncological evaluation after 1,000 cases a Montsouris Institute. J Urol. 2003;169:1261–1266
  45. Martinez-Pineiro L, Caceres F, Sanchez C, et al. Learning curve of laparoscopic radical prostatectomy in a university teaching hospital: Experience after the first 600 cases. Eur Urol. 2006;5(Suppl):914–924
  46. Chuang AY, Nielsen ME, Hernandez DJ, et al. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. J Urol. 2007;178(4 Pt 1):1306–1310
  47. Grossfeld G, Tigrani VS, Nudell D, et al. Management of positive surgical margins after radical prostatectomy (Decision analysis). J Urol. 2000;164:93–100
  48. Polascik TJ, Pearson JD, Partin AW. Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen. Semin Urol Oncol. 1998;16:160–171
  49. Stamey TA, Caldwell M, McNeal JE, et al. The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years?. J Urol. 2004;172(4 Pt 1):1297–1301
  50. Graif T, Loeb S, Roehl KA, et al. Under diagnosis and over diagnosis of prostate cancer. J Urol. 2007;178:88–92
  51. Nelson BA, Shappell SB, Chang SS, et al. Tumor volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int. 2006;97:1169–1172
  52. Buschemeyer WC, Freedland SJ. Obesity and prostate cancer: Epidemiology and clinical implications. Eur Urol. 2007;52:331–343
  53. Castle EP, Atug F, Woods M, et al. Impact of body mass index on outcomes after robot assisted radical prostatectomy. World J Urol. 2008;26:91–95
  54. Matsunaga GS, Ahlering TE, Skarecky DW. Update on robotic laparoscopic radical prostatectomy. Scientific World J. 2006;6:2542–2552
  55. Martorana G, Manferrari F, Bertaccini A, et al. Laparoscopic radical prostatectomy: Oncological evaluation in the early phase of the learning curve comparing to retropubic approach. Arch Ital Urol Androl. 2004;76:1–5
  56. El-Feel A, Davis JW, Deger S, et al. Positive margins after laparoscopic radical prostatectomy: A prospective study of 100 cases performed by 4 different surgeons. Eur Urol. 2003;43:622–626
  57. Smith JA, Chan RC, Chang SS, et al. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J Urol. 2007;178:2385–2389Discussion 2389–90
  58. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? (A systematic review and methodological critique of the literature). Ann Intern Med. 2002;137:511–520
  59. Lunacek A, Schwentner C, Fritsch H, et al. Anatomical radical retropubic prostatectomy: 'Curtain dissection' of the neurovascular bundle. BJU Int. 2005;95:1226–1231
  60. Ohori M, Wheeler TM, Kattan MW, et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol. 1995;154:1818–1824
  61. Boccon-Gibod L, Bertaccini A, Bono AV, et al. Management of locally advanced prostate cancer: A European consensus. Int J Clin Pract. 2003;57:187–194
  62. Marks RA, Koch MO, Lopez-Beltran A, et al. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Hum Pathol. 2007;38:1207–1211
  63. Shuford MD, Cookson MS, Chang SS, et al. Adverse prognostic significance of capsular incision with radical retropubic prostatectomy. J Urol. 2004;172:119–123
  64. Ohori M, Kattan MW, Koh H, et al. Predicting the presence and side of extracapsular extension: A nomogram for staging prostate cancer. J Urol. 2004;171:1844–1849
  65. Shah O, Robbins DA, Melamed J, et al. The New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy. J Urol. 2003;169:2147–2152
  66. Vickers AJ, Bianco FJ, Serio AM, et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst. 2007;99:1171–1177
  67. Vickers AJ, Bianco FJ, Gonen M, et al. Effects of pathologic stage on the learning curve for radical prostatectomy: Evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol. 2008;53:960–966
  68. Pound CR, Partin AW, Eisenberger MA, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281:1591–1597
  69. Grossfeld GD, Chang JJ, Broering JM, et al. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: Data from the CaPSURE database. J Urol. 2000;163:1171–1177
  70. Paulson DF, Moul JW, Walther PJ. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: Long-term results. J Urol. 1990;144:1180–1184
  71. Karakiewicz PI, Eastham JA, Graefen M, et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5,831 patients. Urology. 2005;66:1245–1250
  72. Fesseha T, Sakr W, Grignon D, et al. Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol. 1997;158:2176–2179
  73. Eastham JA, Kuroiwa K, Ohori M, et al. Prognostic significance of location of positive margins in radical prostatectomy specimens. Urology. 2007;70:965–969
  74. Koppie TM, Bianco FJ, Kuroiwa K, et al. The clinical features of anterior prostate cancers. BJU Int. 2006;98:1167–1171
  75. Poulos CK, Koch MO, Eble JN, et al. Bladder neck invasion is an independent predictor of prostate-specific antigen recurrence. Cancer. 2004;101:1563–1568
  76. Aydin H, Tsuzuki T, Hernandez D, et al. Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression. Urology. 2004;64:551–555
  77. Bianco FJ, Grignon DJ, Sakr WA, et al. Radical prostatectomy with bladder neck preservation: Impact of a positive margin. Urology. 2004;64:551–555
  78. Yossepowitch O, Sircar K, Scardino PT, et al. Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. J Urol. 2002;168:2011–2015
  79. Stolzenburg JU, Rabenalt R, Tannapfel A, et al. Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy. Urology. 2006;67:17–21
  80. Barocas DA, Han M, Epstein JI, et al. Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?. Urology. 2001;58:746–751
  81. Pinto F, Prayer-Galetti T, Gardiman M, et al. Clinical and pathological characteristics of patients presenting with biochemical progression after radical retropubic prostatectomy for pathologically organ-confined prostate cancer. Urol Int. 2006;76:202–208
  82. Swindle P, Eastham JA, Ohori M, et al. Do margins matter? (The prognostic significance of positive surgical margins in radical prostatectomy specimens). J Urol. 2005;174:903–907
  83. Watson RB, Civantos F, Soloway MS. Positive surgical margins with radical prostatectomy: Detailed pathological analysis and prognosis. Urology. 1996;48:80–90
  84. D'Amico AV, Whittington R, Malkowicz SB, et al. An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: Implications on the use of adjuvant therapy. Urology. 1996;47:538–547
  85. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer. 1993;71:3582–3593
  86. Paulson DF, Stone AR, Walther PJ, et al. Radical prostatectomy: Anatomical predictors of success or failure. J Urol. 1986;136:1041–1043
  87. Weldon VE, Tavel FR, Neuwirth H, et al. Failure of focal prostate cancer on biopsy to predict focal prostate cancer: The importance of prevalence. J Urol. 1995;154:1074–1077
  88. Blute ML, Bostwick DG, Seay TM, et al. Pathologic classification of prostate carcinoma: The impact of margin status. Cancer. 1998;82:902–908
  89. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: A randomized controlled trial (EORTC trial 22911). Lancet. 2005;366:572–578
  90. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA. 2006;296:2329–2335
  91. Leventis AK, Shariat SF, Kattan MW, et al. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2001;19:1030–1039
  92. Catton C, Milosevic M. Salvage radiotherapy following radical prostatectomy. World J Urol. 2003;21:243–252
  93. Stephenson AJ, Scardino PT, Kattan MW, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007;25:2035–2041
  94. Messing EM, Manola J, Sarosdy M, et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med. 1999;341:1781–1788
  95. Bolla M, Descotes JL, Artignan X, et al. Adjuvant treatment to radiation: Combined hormone therapy and external radiotherapy for locally advanced prostate cancer. BJU Int. 2007;100(Suppl 2):44–47
  96. Studer UE, Whelan P, Albrecht W, et al. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organization for Research and Treatment of Cancer (EORTC) Trial 30891. J Clin Oncol. 2006;24:1868–1876
  97. Iversen P, Johansson JE, Lodding P, et al. Scandinavian Prostate Cancer Group Bicalutamide 150 mg in addition to standard care for patients with early nonmetastatic prostate cancer: Updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years. Scand J Urol Nephrol. 2006;40:441–452
  98. Parker C, Clarke N, Logue J, et al. The RADICALS Trial Management Group RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery). Clin Oncol (R Coll Radiol). 2007;19:167–171

PII: S1078-1439(09)00268-3

doi: 10.1016/j.urolonc.2009.08.015

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 197-204 , March 2010

Article Tools